Peter Elliott

Trader’s Round Up: Nordstrom, Inc. (JWN), Amkor Technology, Inc. (AMKR), People’s United Financial, Inc. (PBCT)

Nordstrom, Inc. (JWN) grew with the stock adding 1.5% or $0.68 to close at $46.12 on active trading volume of 4.03M compared its three months average trading volume of 3.19M. The Seattle Washington 98101 based company operating under the Apparel Stores industry has been trending down for the last 52 weeks, with the shares price now -9.02% down for the period and down by -3.78% so far this year. With price target of $50.76 and a 33.53% rebound from 52-week low, Nordstrom, Inc. has plenty of upside potential, making it a hold with a view buy.

Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for men, women, and children in the United States and Canada. It operates through two segments, Retail and Credit. The Retail segment offers a selection of brand name and private label merchandise through various channels, including Nordstrom branded full-line stores and online store at Nordstrom.com; Nordstrom Rack stores; Nordstromrack.com and HauteLook; and other retail channels, including Trunk Club showrooms and TrunkClub.com, Jeffrey boutiques, and clearance store that operates under the name Last Chance. The Credit segment operates Nordstrom fsb, a federal savings bank, which provides a private label credit card, two Nordstrom VISA credit cards, and a debit card. Its credit and debit cards feature a shopping-based loyalty program. As of February 1, 2017, the company operated 349 stores in 40 states, including 123 full-line stores in the United States, Canada, and Puerto Rico; 215 Nordstrom Rack stores; 2 Jeffrey boutiques; and 2 clearance stores. Nordstrom, Inc. also sells its products through catalogs. The company was founded in 1901 and is based in Seattle, Washington.

Amkor Technology, Inc. (AMKR) dropped $-0.01 to close the day at a new closing price of $9.6, a -0.1% decrease in value from its previous closing price that moved the stock 134.15% above its 52 week low of $4.5. A total of 3.98M shares exchanged hands during the day compared with its three month average trading volume of 1.61M. The stock, which fluctuated between $9.28 and $9.63 during the day, currently situated -23.08% below its 52 week high. The stock is down by -1.94% in the past one month and down by -15.57% over the past three months. With a one year target estimate of $8.5 and RSI of 42.9, the stock still has upside potential, making it a hold for now.

Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally. The company offers turnkey packaging and test services, including semiconductor wafer bumps, wafer probes, wafer backgrinds, package design, packaging, and test and drop shipment services. Its packages employ wirebond, flip chip, and copper clip interconnect technologies. The company also provides semiconductor testing services, such as wafer testing or probe, and final test services; flip chip chip scale package products for use in smartphones, tablets, and other mobile consumer electronic devices; flip chip stacked chip scale packages that are used to stack memory, and as applications processors in mobile devices; flip chip ball grid array (BGA) products for various networking, storage, computing, and consumer applications; and flip chip molded BGA packages. In addition, it offers leadframe packages that are used in electronic devices for low to medium pin count applications; substrate-based wirebond packages that are used to connect a die to a substrate; micro-electro-mechanical systems packages that are miniaturized mechanical and electro-mechanical devices; and system-in-package modules, which are used in RF and front end modules, baseband processing, connectivity, fingerprint sensors, display and touch screen drivers, sensors and MEMS, and NAND memory and solid state drives. The company primarily serves integrated device manufacturers, fabless semiconductor companies, and contract foundries, as well as communications, consumer, networking, computing, and automotive and industrial markets. Amkor Technology, Inc. was founded in 1968 and is headquartered in Tempe, Arizona.

People’s United Financial, Inc. (PBCT) shares were up in last trading by 0.26% to $19.16. It experienced higher than average volume on day. The stock increased in value by almost 3.74% over the past week and grew 1.16% in the past month. It is currently trading 0.63% above its 50 day moving average and 16.83% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -3.96% decrease in value from its one year high of $20.13. The RSI indicator value of 56.2, lead us to believe that it is a hold for now.

People’s United Financial, Inc. operates as the bank holding company for People’s United Bank, National Association that provides commercial banking, retail banking, and wealth management services to individual, corporate, and municipal customers. The company operates in two segments, Commercial Banking and Retail Banking. The Commercial Banking segment offers commercial real estate lending, commercial and industrial lending, and commercial deposit gathering services. This segment also provides equipment financing; cash management, correspondent banking, and municipal banking services; and institutional trust, corporate trust, private banking, and insurance services. The Retail Banking segment offers consumer lending, including residential mortgage and home equity lending; and consumer deposit gathering services. This segment also provides brokerage, financial advisory, investment management, life insurance, and non-institutional trust services. In addition, the company offers online banking, investment trading, and telephone banking services. It operates through a network of 396 branches and 594 ATMs in Connecticut, southeastern New York, Massachusetts, Vermont, New Hampshire, and Maine. People’s United Financial, Inc. was founded in 1842 and is headquartered in Bridgeport, Connecticut.

 

Stocks Buzz: American Eagle Outfitters, Inc. (AEO), Abercrombie & Fitch Co. (ANF), Uranium Energy Corp. (UEC)

American Eagle Outfitters, Inc. (AEO) managed to rebound with the stock declining 0% or $0 to close the day at $15.48 on light trading volume of 3.13M shares, compared to its three month average trading volume of 5.23M. The Pittsburgh Pennsylvania 15203 based company has been outperforming the apparel stores group over the past 52 weeks, with the stock gaining 11.98%, compared to the industry which has dropped -3.36% over the same period. With RSI of 52.13, the stock should still continue to rise and get closer to its one year target estimate of $18.29, making it a hold for now.

American Eagle Outfitters, Inc. operates as a specialty retailer offering on-trend clothing, accessories, and personal care products under the American Eagle Outfitters and Aerie brands. The company provides denim, bottoms, and other apparel, as well as footwear and accessories for men and women; and intimates, including bras, undies, swim, and other products, as well as apparel and personal care products for women. In addition, it offers sports apparel under the Tailgate brand; and menswear products under the Todd Snyder New York brand name. The company operates approximately 1,000 stores in the United States, Canada, Mexico, China, Hong Kong, and the United Kingdom, and ships to 81 countries through its websites. It also offers its merchandise at 151 stores operated by licensees in 22 countries, as well as through its Websites at ae.com, aerie.com, TailgateClothing.com, and ToddSnyder.com. American Eagle Outfitters, Inc. was founded in 1977 and is headquartered in Pittsburgh, Pennsylvania.

Abercrombie & Fitch Co. (ANF) retreated with the stock falling -0.56% or $-0.07 to close at $12.47 on light trading volume of 3.11M compared its three months average trading volume of 3.49M. The New Albany Ohio 43054 based company operating under the Apparel Stores industry has been trending down for the last 52 weeks, with the shares price now -49.73% down for the period and up by 3.92% so far this year. With price target of $13.4 and a 14.3% rebound from 52-week low, Abercrombie & Fitch Co. has plenty of upside potential, making it a hold with a view buy.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer of casual apparel. The company sells knit and woven shirts, graphic T-shirts, fleece, jeans and woven pants, shorts, sweaters, and outerwear; personal care products; and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, and Hollister brand names. As of March 2, 2016, it operated through 754 stores in the United States; and 178 stores in Canada, Europe, Asia, and the Middle East. The company sells its products through its stores and direct-to-consumer sales. Abercrombie & Fitch Co. was founded in 1892 and is headquartered in New Albany, Ohio.

Uranium Energy Corp. (UEC) failed to extend gains with the stock declining -5.98% or $-0.11 to close the day at $1.73 on higher than average trading volume of 3.11M shares, compared to its three month average trading volume of 2.22M. The Vancouver British Columbia V6E 2Y3 based company has been outperforming the industrial metals & minerals companies by 87.8989% for last three months and its recent gains have pushed the stock slightly up 54.46% YTD, versus the industrial metals & minerals industry which is up 17.86% for the same period. The RSI of 59.38 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Uranium Energy Corp. engages in the exploration, pre-extraction, extraction, and processing of uranium concentrates on projects located in the United States and the Republic of Paraguay. As of July 31, 2016, it had mineral rights in uranium projects located in the states of Arizona, Colorado, New Mexico, Texas, and Wyoming, as well as in the Republic of Paraguay. The company was formerly known as Carlin Gold Inc. and changed its name to Uranium Energy Corp. in January 2005. Uranium Energy Corp. was incorporated in 2003 and is based in Corpus Christi, Texas.

 

Stocks Trend Analysis: F.N.B. Corporation (FNB), Seacoast Banking Corporation of Florida (SBCF), Rowan Companies plc (RDC)

F.N.B. Corporation (FNB) continued its upward trend with the stock climbing 0.91% or $0.14 to close the day at $15.51 on active trading volume of 2.99M shares, compared to its three month average trading volume of 2.05M. The Pittsburgh Pennsylvania 15212 based company has been outperforming the regional – southeast banks group over the past 52 weeks, with the stock gaining 30.46%, compared to the industry which has advanced 62.97% over the same period. With RSI of 56.42, the stock should still continue to rise and get closer to its one year target estimate of $16.93, making it a hold for now.

F.N.B. Corporation, a financial holding company, provides a range of financial services to consumers, corporations, governments, and small- to medium-sized businesses primarily in Pennsylvania, eastern Ohio, and northern West Virginia. It operates through four segments: Community Banking, Wealth Management, Insurance, and Consumer Finance. The Community Banking segment offers various deposit products, such as commercial and individual demand, savings, and time deposit accounts; and commercial, mortgage, and individual installment loans. The Wealth Management segment provides a range of personal and corporate fiduciary services, including the administration of decedent and trust estates; investment products and services for customers through a networking relationship with a third-party licensed brokerage firm; and investment programs consisting of mutual funds, annuities, stocks, and bonds for individuals, corporations, and retirement funds, as well as community banking customers. The Insurance segment operates as a full-service insurance brokerage agency that offers commercial and personal insurance products through various carriers to businesses and individuals; acts as a reinsurer to underwrite credit life, and accident and health insurance products; and provides title insurance products. The Consumer Finance segment is primarily involved in making personal installment loans to individuals; and purchasing installment sales finance contracts from retail merchants. The company also offers mezzanine financing options for small-to medium-sized businesses; and new or used equipment commercial loans and leasing services. As of December 31, 2015, it had 288 community banking offices in Pennsylvania, Ohio, Maryland, and West Virginia; and 76 consumer finance offices in Pennsylvania, Ohio, Tennessee, and Kentucky. F.N.B. Corporation was founded in 1974 and is headquartered in Pittsburgh, Pennsylvania.

Seacoast Banking Corporation of Florida (SBCF) grew with the stock adding 0.96% or $0.23 to close at $24.2 on light trading volume of 2.99M compared its three months average trading volume of 244.72K. The Stuart Florida 34994 based company operating under the Regional – Mid-Atlantic Banks industry has been trending up for the last 52 weeks, with the shares price now 62.85% up for the period and up by 9.7% so far this year. With price target of $23.66 and a 73.35% rebound from 52-week low, Seacoast Banking Corporation of Florida has plenty of upside potential, making it a hold with a view buy.

Seacoast Banking Corporation of Florida operates as the bank holding company for Seacoast National Bank that provides community banking services to the commercial, small business, and retail customers in Florida. It offers various transaction and savings deposit products; secured and unsecured loan products, including revolving credit facilities, and letters of credit and related financial guarantees; and securities and annuity products. The company also provides trust and asset management services to retirement plans, corporations, and individuals; treasury management services; brokerage services; and Internet and mobile banking services. As of December 31, 2015, it had 42 branch offices, 5 commercial lending offices, and its main office in Florida. The company was founded in 1926 and is based in Stuart, Florida.

Rowan Companies plc (RDC) failed to extend gains with the stock declining -3.43% or $-0.65 to close the day at $18.31 on higher than average trading volume of 2.95M shares, compared to its three month average trading volume of 2.94M. The Houston Texas 77056 based company has been outperforming the oil & gas drilling & exploration companies by 22.1771% for last three months and its recent gains have offset losses to -3.07% YTD, versus the oil & gas drilling & exploration industry which is up 5.01% for the same period. The RSI of 45.95 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Rowan Companies plc provides offshore oil and gas contract drilling services. It operates a fleet of 31 mobile offshore drilling units, including 27 self-elevating jack-up rigs and 4 ultra-deepwater drillships. The company operates in the United States Gulf of Mexico, the United Kingdom, and Norwegian sectors of the North Sea, the Middle East, and Trinidad. Rowan Companies plc was founded in 1923 and is based in Houston, Texas.

 

Momentum Stocks: News Corporation (NWSA), Anthera Pharmaceuticals, Inc. (ANTH), Palatin Technologies, Inc. (PTN)

News Corporation (NWSA) grew with the stock adding 0.15% or $0.02 to close at $13.1 on active trading volume of 2.67M compared its three months average trading volume of 2.34M. The New York New York 10036 based company operating under the Broadcasting – TV industry has been trending up for the last 52 weeks, with the shares price now 21.09% up for the period and up by 14.31% so far this year. With price target of $14.48 and a 26.98% rebound from 52-week low, News Corporation has plenty of upside potential, making it a hold with a view buy.

News Corporation, a media and information services company, focuses on creating and distributing content to consumers and businesses worldwide. The company distributes content and data products, such as The Wall Street Journal, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, Barron’s, MarketWatch, Dow Jones Private Markets, and DJX through various media channels, including newspapers, newswires, Websites, newsletters, magazines, proprietary databases, conferences, and video, as well as applications for mobile devices, tablets, and electronic readers. It also owns and operates daily, Sunday, weekly, and bi-weekly newspapers, including The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other Websites. In addition, the company provides home-delivered shopper media, such as free-standing inserts and direct mail products; in-store marketing products and services primarily to consumer packaged goods manufacturers; in-store merchandising services; and digital marketing solutions. Further, it publishes general fiction, nonfiction, children’s, and religious books; and offers sports programming services with seven television channels distributed through cable, satellite and IP, various interactive viewing applications, and broadcast rights to live sporting events. Additionally, the company provides digital advertising services for property and property-related services on Websites and mobile applications; online real estate services; and professional software and services products, including Top Producer, TigerLead, and ListHub, as well as operates residential and commercial property Websites. News Corporation is headquartered in New York, New York.

Anthera Pharmaceuticals, Inc. (ANTH) had a light trading with around 2.65M shares changing hands compared to its three month average trading volume of 2M. The stock traded between $0.6255 and $0.73 before closing at the price of $0.71 with 11.79% change on the day. The Hayward California 94545 based company is currently trading 39.45% above its 52 week low of $0.51 and -85.49% below its 52 week high of $4.9. Both the RSI indicator and target price of  and $2.85 respectively, lead us to believe that it could rise over the coming weeks.

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. The company’s Phase III product candidates include liprotamase or Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod that targets B-cell activating factor associated with various B-cell mediated autoimmune diseases, including systemic lupus erythematosus, lupus nephritis, and others. It also develops Blisibimod, which is in Phase II clinical study for the treatment of Immunoglobulin A nephropathy. The company was founded in 2004 and is headquartered in Hayward, California.

Palatin Technologies, Inc. (PTN) saw its value decrease by -3.31% as the stock dropped $-0.01 to finish the day at a closing price of $0.38. The stock was lighter in trading and has fluctuated between $0.36-$0.9 per share for the past year. The shares, which traded within a range of $0.37 to $0.39 during the day, are down by -30.91% in the past three months and down by -27.48% over the past six months. It is currently trading -9.92% below its 20 day moving average and -21.51% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $3.83 a share over the next twelve months. The current relative strength index (RSI) reading is 34.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s principal product is Bremelanotide, an as needed subcutaneous injectable peptide melanocortin receptor agonist, which is in the Phase III clinical studies for the treatment of premenopausal women with hypoactive sexual desire disorder (HSDD). Its drug development programs also include Melanocortin receptor-4 (MC4r) peptides and small molecule agonists that are under the preclinical trials for the treatment of conditions responsive to MC4r activation, including female sexual dysfunction, HSDD, erectile dysfunction, obesity, and diabetes; and Melanocortin receptor-1 peptide agonists, which are under preclinical studies for the treatment of inflammatory and dermatologic disease indications, as well as other Melanocortin receptors. In addition, the company is involved in the development of natriuretic peptide receptor-specific programs, including PL-3994, a natriuretic peptide receptor-A, which is in Phase II clinical studies for treatment of heart failure, acute exacerbations of asthma, and refractory hypertension. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.

 

Traders Watch list: Biocept, Inc. (BIOC), Sprouts Farmers Market, Inc. (SFM), Two Harbors Investment Corp. (TWO)

Biocept, Inc. (BIOC) saw its value decrease by -0.47% as the stock dropped $-0.01 to finish the day at a closing price of $2.1. The stock was lighter in trading and has fluctuated between $0.74-$5.64 per share for the past year. The shares, which traded within a range of $2.01 to $2.25 during the day, are up by 143.34% in the past three months and up by 296.23% over the past six months. It is currently trading 25.94% above its 20 day moving average and 60.59% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 62.05.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Biocept, Inc., a cancer diagnostics company, develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company’s cancer assays provide an information to oncologists and other physicians that enable them to select personalized treatment for their patients based on detailed data on the characteristics of tumors. It offers assays for solid tumor indications, such as breast cancer, lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma. The company sells its cancer diagnostic assays directly to oncologists and other physicians at private and group practices, hospitals, and cancer centers in the United States, as well as markets its clinical trial and research services to pharmaceutical and biopharmaceutical companies, and clinical research organizations. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.

Sprouts Farmers Market, Inc. (SFM) shares were down in last trading by -0.48% to $18.8. It experienced lighter than average volume on day. The stock increased in value by almost 3.81% over the past week and fell -7.02% in the past month. It is currently trading -4.03% below its 50 day moving average and -13.78% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -37.33% decrease in value from its one year high of $30. The RSI indicator value of 45.66, lead us to believe that it is a hold for now.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Two Harbors Investment Corp. (TWO) traded within a range of $8.86 to $9.02 after opening the day at $8.93. The company has seen its stock increase in value by 3.44% so far this year. The stock was up close to 0.89% on light volume in last trading session and closed at $9.02 per share. After the recent gain, the stock is currently holding 0.22% above its 52 week high of $9.18 and 38.36% above its 12-month low of $7.45. The shares are up by over 11.38% in the last three months, and the RSI indicator value of 69.16 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Two Harbors Investment Corp. operates as a real estate investment trust (REIT) that focuses on investing in, financing, and managing residential mortgage-backed securities (RMBS), residential mortgage loans, mortgage servicing rights, commercial real estate and other financial assets. The company’s target assets include agency RMBS collateralized by fixed rate mortgage loans, adjustable rate mortgage loans, hybrid mortgage loans, or derivatives; and non-agency RMBS collateralized by prime mortgage loans, Alt-A mortgage loans, pay-option ARM mortgage loans, and subprime mortgage loans. Its target assets also comprise prime nonconforming and credit sensitive residential mortgage loans; floating and fixed rate commercial real estate loans; CMBS collateralized by commercial real estate loans; and other assets, such as asset backed securities and certain non-hedging transactions. The company qualifies as a REIT for federal income tax purposes. As a REIT, the company would not be subject to federal income tax, if it distributes at least 90% of net taxable income to its stockholders. Two Harbors Investment Corp. was incorporated in 2009 and is headquartered in New York, New York.

 

Stocks Highlights: Flowserve Corporation (FLS), 8×8, Inc. (EGHT), TherapeuticsMD, Inc. (TXMD)

Flowserve Corporation (FLS) had a active trading with around 2.01M shares changing hands compared to its three month average trading volume of 1.25M. The stock traded between $50.63 and $51.25 before closing at the price of $51.2 with 0.53% change on the day. The Irving Texas 75039 based company is currently trading 31.36% above its 52 week low of $39.13 and -1.73% below its 52 week high of $52.5. Both the RSI indicator and target price of 58.32 and $48.64 respectively, lead us to believe that it should be put on hold over the coming weeks.

Flowserve Corporation designs, manufactures, distributes, and services industrial flow management equipment worldwide. The company operates through three segments: Engineered Product Division (EPD), Industrial Product Division (IPD), and Flow Control Division (FCD). The EPD segment offers custom and other engineered pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, and related services, as well as manufactures gas-lubricated mechanical seals used in high-speed compressors. The IPD segment provides pre-configured engineered pumps and pump systems, and related products and services, including submersible motors and specialty products. The FCD segment offers industrial valve and automation solutions comprising isolation and control valves, actuation, controls, and related equipment; and energy management products, such as steam traps, boiler controls and condensate, and energy recovery systems. Its products are used to control, direct, and manage the flow of liquids and gases. The company also offers aftermarket equipment services consisting of installation, advanced diagnostics, repair, and retrofitting. It primarily serves oil and gas, chemical, power generation, and water management markets, as well as general industries that include mining and ore processing, pharmaceuticals, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was founded in 1912 and is headquartered in Irving, Texas.

8×8, Inc. (EGHT) continued its downward trend with the stock declining -1% or $-0.15 to close the day at $14.85 on light trading volume of 1.99M shares, compared to its three month average trading volume of 631.62K. The San Jose California 95131 based company has been outperforming the diversified communication services group over the past 52 weeks, with the stock gaining 35.62%, compared to the industry which has dropped -2.47% over the same period. With RSI of 39.56, the stock should still continue to rise and get closer to its one year target estimate of $18.2, making it a hold for now.

8×8, Inc. provides cloud-based, enterprise-class software solutions for small and medium businesses, mid-market, and distributed enterprises worldwide. The company operates in two segments, Americas and Europe. The company’s pure-cloud offering combines voice, conferencing, messaging, and video with integrated workflows and big data analytics on a single platform. It provides 8×8 Virtual Office, a voice as a service with a robust business feature set; 8×8 Virtual Office Pro software that enables employees and workgroups to communicate with each other using chat or text messages sent via the short message service; 8×8 Virtual Contact Center, a voice, chat, voicemail, and e-mail call center. The company integrates its services with third-party applications and platforms, including enterprise resource planning, customer relations management, human capital management, and other proprietary application suites. It markets its services to end users through direct sales force, Website, and channel partners. The company serves approximately 45,700 business customers. 8×8, Inc. was founded in 1987 and is headquartered in San Jose, California.

TherapeuticsMD, Inc. (TXMD) shares were up in last trading by 0.51% to $5.89. It experienced lighter than average volume on day. The stock decreased in value by almost -0.67% over the past week and grew 2.61% in the past month. It is currently trading -0.14% below its 50 day moving average and -15.54% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -36.6% decrease in value from its one year high of $9.29. The RSI indicator value of 55.88, lead us to believe that it is a hold for now.

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes prescription and over-the-counter product lines, including prenatal vitamins, iron supplements, and natural menopause relief products under the vitaMedMD brand, as well as generic formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. Its pipeline of hormone therapy drug candidates include TX-001HR, a combination of estradiol and progesterone drug candidate under clinical trials for the treatment of moderate to severe vasomotor symptoms due to menopause; TX-002HR, a natural progesterone formulation for the treatment of secondary amenorrhea without the potentially allergenic component of peanut oil; and TX-004HR, an applicator-free vaginal estradiol softgel drug candidate for the treatment of vulvar and vaginal atrophy in post-menopausal women with vaginal linings that do not receive enough estrogen. The company markets its products primarily through a direct national sales force to health care providers in the OB/GYN market space, as well as directly through its Website. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

 

Worth Watching Stocks: Rex Energy Corporation (REXX), RSP Permian, Inc. (RSPP), Merrimack Pharmaceuticals, Inc. (MACK)

Rex Energy Corporation (REXX) saw its value decrease by -7.3% as the stock dropped $-0.05 to finish the day at a closing price of $0.69. The stock was lighter in trading and has fluctuated between $0.23-$2.43 per share for the past year. The shares, which traded within a range of $0.675 to $0.75 during the day, are up by 96% in the past three months and up by 12.46% over the past six months. It is currently trading -2.97% below its 20 day moving average and 15.6% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 53.92.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Rex Energy Corporation operates as an independent oil, natural gas liquid, and natural gas company in the Appalachian and Illinois basins in the United States. The company focuses on the Marcellus Shale, Utica Shale, and Burkett Shale drilling and exploration activities in the Appalachian Basin, as well as on developmental oil drilling on its properties in the Illinois Basins. As of December 31, 2015, it had estimated proved reserves of 680.4 billion cubic feet equivalent; and owned interests in approximately 1,819 oil and natural gas wells. Rex Energy Corporation was founded in 2007 and is headquartered in State College, Pennsylvania.

RSP Permian, Inc. (RSPP) shares were up in last trading by 1.39% to $43.7. It experienced higher than average volume on day. The stock increased in value by almost 7.58% over the past week and grew 1.96% in the past month. It is currently trading 0.57% above its 50 day moving average and 13.64% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -6.86% decrease in value from its one year high of $46.92. The RSI indicator value of 58.54, lead us to believe that it is a hold for now.

RSP Permian, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of unconventional oil and associated liquids-rich natural gas reserves in the Permian Basin of West Texas. It owns interest in contiguous acreage blocks in the core of the Midland Basin, a sub-basin of the Permian Basin, primarily in the adjacent counties of Midland, Martin, Andrews, Dawson, Ector, and Glasscock. RSP Permian, Inc. was founded in 2010 and is headquartered in Dallas, Texas.

Merrimack Pharmaceuticals, Inc. (MACK) traded within a range of $3.17 to $3.28 after opening the day at $3.22. The company has seen its stock decrease in value by -20.59% so far this year. The stock was up close to 0.31% on light volume in last trading session and closed at $3.24 per share. After the recent gain, the stock is currently holding -64.08% below its 52 week high of $9.02 and 14.49% above its 12-month low of $2.83. The shares are down by over -51.13% in the last three months, and the RSI indicator value of 41.62 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer primarily in the United States. The company offers ONIVYDE that is used for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. Its therapeutic oncology candidates in clinical development include MM-398, which is in Phase II clinical trials for the treatment of patients with previously untreated, metastatic pancreatic adenocarcinoma; Phase I clinical trials for the treatment of patients with glioma, pediatric solid tumors, and gastrointestinal tumors; and Phase I clinical trials for treating metastatic breast cancer. The company’s therapeutic oncology candidates also include MM-302 that is in Phase II clinical trials for the treatment of patients with ErbB2 (HER2) positive, locally advanced or metastatic breast cancer; and MM-121, which is in Phase II clinical trial for the treatment of patients with heregulin positive, advanced non-small cell lung cancer. In addition, its therapeutic oncology candidates consist of MM-141 that is in Phase II clinical trials for the treatment of previously untreated metastatic pancreatic cancer patients who have high serum levels of free IGF-1; and MM-151 and MM-141, which are in Phase I clinical trials for the treatment of patients with solid tumors. The company has license and collaboration agreements with Baxter International Inc., Baxter Healthcare Corporation, and Baxter Healthcare SA; development, license, and supply agreement with Watson Laboratories, Inc.; sublicense and collaboration agreement with PharmaEngine, Inc.; collaboration agreements with Dyax Corp. and Adimab LLC,; and license agreement with University of California. Merrimack Pharmaceuticals, Inc. was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

 

Stocks in Review: Summit Materials, Inc. (SUM), Splunk Inc. (SPLK), Myriad Genetics, Inc. (MYGN)

Summit Materials, Inc. (SUM) traded within a range of $24.42 to $24.86 after opening the day at $24.5. The company has seen its stock increase in value by 3.83% so far this year. The stock was up close to 0.82% on light volume in last trading session and closed at $24.7 per share. After the recent gain, the stock is currently holding -6.65% below its 52 week high of $26.46 and 59.46% above its 12-month low of $14.97. The shares are down by over -0.28% in the last three months, and the RSI indicator value of 51.96 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Summit Materials, Inc., through its subsidiaries, produces and sells construction materials and related downstream products. Its products include crushed stone, construction sand and gravel, cement and ready-mixed concrete, asphalt paving mixes, granite and trap rock, and limestone and concrete products. The company also provides paving and related services to the construction industry. In addition, it operates municipal waste, construction, and demolition debris landfills; and liquid asphalt terminal operations. Summit Materials, Inc. was founded in 2009 and is headquartered in Denver, Colorado.

Splunk Inc. (SPLK) managed to rebound with the stock climbing 2% or $1.24 to close the day at $63.17 on light trading volume of 1.66M shares, compared to its three month average trading volume of 1.83M. The San Francisco California 94107 based company has been outperforming the application software group over the past 52 weeks, with the stock gaining 83%, compared to the industry which has advanced 26.25% over the same period. With RSI of 70.21, the stock should still continue to rise and get closer to its one year target estimate of $70.67, making it a hold for now.

Splunk Inc. provides software solutions that enable organizations to gain real-time operational intelligence in the United States and internationally. The company’s products enable users to collect, index, search, explore, monitor, and analyze data regardless of format or source. It offers Splunk Enterprise, a machine data platform with collection, indexing, search, reporting, analysis, alerting, monitoring, and data management capabilities; and Splunk Cloud service. The company also provides Splunk Light, which offers log search and analysis for small IT environments; and Hunk, a Splunk analytics software, for exploring, analyzing, and visualizing data stored in Hadoop and Amazon S3. In addition, it offers Splunk Enterprise Security, which addresses emerging security threats; Splunk User Behavior Analytics that detects cyber-attacks and insider threats; and Splunk IT Service Intelligence, which monitors health and key performance indicators of critical IT services, as well as Splunk App for AWS to ensure cloud security and compliance; Splunk App for Stream to capture, analyze, and correlate network wire data; and DB Connect to get enterprise context; Palo Alto Networks App for Splunk to gain visibility to Palo Alto Networks firewalls; and Splunk App for Salesforce. Further, the company operates Splunkbase and Splunk Answers Websites, which provide an environment to share apps, collaborate on the use of its software, and provide community-based support, as well as offers application programming interfaces and software development kits. Additionally, it offers maintenance and customer support, training, and consulting and implementation services. The company serves cloud and online services, education, financial services, government, healthcare/pharmaceuticals, industrials/manufacturing, media/entertainment, retail/ecommerce, technology, and telecommunications industries. Splunk Inc. was incorporated in 2003 and is headquartered in San Francisco, California.

Myriad Genetics, Inc. (MYGN) gained $0.35 to close the day at a new closing price of $17.38, a 2.03% increase in value from its previous closing price that moved the stock 14.69% above its 52 week low of $15.15. A total of 1.65M shares exchanged hands during the day compared with its three month average trading volume of 1.38M. The stock, which fluctuated between $16.85 and $17.41 during the day, currently situated -56.28% below its 52 week high. The stock is up by 9.9% in the past one month and down by -2.88% over the past three months. With a one year target estimate of $18.92 and RSI of 59.95, the stock still has upside potential, making it a hold for now.

Myriad Genetics, Inc., a personalized medicine company, focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. It operates through two segments, Diagnostics and Other. The Diagnostics segment primarily provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing disease; identify a patient’s likelihood of responding to drug therapy; guide a patient’s dosing to ensure optimal treatment; and assess a patient’s risk of disease progression and disease recurrence. The Other segment provides testing products and services to the pharmaceutical, biotechnology, and medical research industries; and research and development, and clinical services for patients. Its molecular diagnostic DNA sequencing tests include myRisk Hereditary cancer, a test for hereditary cancers; BRACAnalysis and BART, which are tests for hereditary breast and ovarian cancers; BRACAnalysis CDx test for use in identifying ovarian cancer patients with suspected deleterious germline; and Tumor BRACAnalysis CDx test that is used to predict DNA damaging agents, such as platinum based chemotherapy agents and poly ADP ribose inhibitors. The company also provides COLARIS test for colorectal and uterine cancers; COLARIS AP test for colorectal cancer; Vectra DA protein detection test for assessing the disease activity of rheumatoid arthritis; Prolaris, a RNA expression test for prostate cancer; EndoPredict RNA expression test for breast cancer; myPath Melanoma RNA expression test for diagnosing melanoma; myChoice homologous recombination deficiency (HRD) test to measure three modes of HRD; and myPlan lung cancer, an RNA expression test for lung cancer. Myriad Genetics, Inc. has collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.

 

Stocks To Watch: Stillwater Mining Company (SWC), HD Supply Holdings, Inc. (HDS), Cytori Therapeutics, Inc. (CYTX)

Stillwater Mining Company (SWC) traded within a range of $16.99 to $17.11 after opening the day at $17. The company has seen its stock increase in value by 5.83% so far this year. The stock was up close to 0.18% on light volume in last trading session and closed at $17.05 per share. After the recent gain, the stock is currently holding -2.57% below its 52 week high of $17.5 and 150.37% above its 12-month low of $6.88. The shares are up by over 13.36% in the last three months, and the RSI indicator value of 51.59 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Stillwater Mining Company engages in the development, extraction, processing, smelting, and refining of platinum group metals (PGMs). It operates through Mine Production, PGM Recycling, Canadian Properties, and South American Properties segments. The company explores for palladium, platinum, and associated metals, as well as for gold, silver, nickel, copper, and rhodium ores. It conducts its mining operations at the Stillwater mine located near Nye, Montana; and at the East Boulder mine located in Sweet Grass County, Montana. The company also owns and operates a smelter and base metal refinery located in Columbus, Montana, as well as recycles spent catalyst and other industrial source materials. In addition, it develops and explores the Marathon PGM-copper property situated in Northern Ontario, Canada; and the Altar porphyry copper-gold property located in the San Juan Province of Argentina, as well as owns the Geordie Lake property situated in Ontario, Canada. The company was founded in 1992 and is headquartered in Littleton, Colorado.

HD Supply Holdings, Inc. (HDS) continued its downward trend with the stock declining -0.14% or $-0.06 to close the day at $43.08 on light trading volume of 1.47M shares, compared to its three month average trading volume of 2.09M. The Atlanta Georgia 30339 based company has been outperforming the industrial equipment wholesale group over the past 52 weeks, with the stock gaining 66.27%, compared to the industry which has advanced 36.13% over the same period. With RSI of 53.35, the stock should still continue to rise and get closer to its one year target estimate of $47.13, making it a hold for now.

HD Supply Holdings, Inc. operates as an industrial distributor in North America. The company’s Facilities Maintenance segment offers electrical and lighting items, plumbing, appliances, janitorial supplies, hardware, kitchen and bath cabinets, window coverings, textiles and guest amenities, healthcare maintenance, and water and wastewater treatment products, as well as heating, ventilating, and air conditioning products. Its Waterworks segment provides pipes, fittings, valves, hydrants, and meters for use in the construction, maintenance, and repair of water and waste-water systems, as well as fire-protection systems; and smart meters, fusible piping solutions, and engineered treatment plant products and services. The company’s Construction & Industrial—White Cap segment offers tilt-up brace systems, forming and shoring systems, concrete chemicals, hand and power tools, cutting tools, rebar, ladders, safety and fall arrest equipment, screws and fasteners, sealants and adhesives, drainage pipes, geo-synthetics, erosion and sediment control equipment, and other engineered materials used in non-residential and residential construction. Its Corporate & Other segment provides home improvement solutions, such as light remodeling and construction supplies, kitchen and bath cabinets, windows, plumbing materials, electrical equipment, and other products; and interior solutions comprising floorings, cabinets, countertops, and window coverings, as well as design center services. It serves contractors, maintenance professionals, home builders, industrial businesses, and government entities. The company was formerly known as HDS Investment Holding, Inc. and changed its name to HD Supply Holdings, Inc. in April 2013. HD Supply Holdings, Inc. is headquartered in Atlanta, Georgia.

Cytori Therapeutics, Inc. (CYTX) gained $0.02 to close the day at a new closing price of $1.99, a 1.02% increase in value from its previous closing price that moved the stock 46.32% above its 52 week low of $1.36. A total of 1.47M shares exchanged hands during the day compared with its three month average trading volume of 215.84K. The stock, which fluctuated between $1.91 and $2.13 during the day, currently situated -63.15% below its 52 week high. The stock is up by 30.07% in the past one month and up by 10.56% over the past three months. With a one year target estimate of $5.58 and RSI of 78.26, the stock still has upside potential, making it a sell for now.

Cytori Therapeutics, Inc., a biotechnology company, develops cellular therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, including stem cells for the treatment of patients with scleroderma hand dysfunction, orthopedic disorders, urinary incontinence, and thermal burns combined with radiation injury. It also offers Celution System devices, proprietary enzymes, and sterile consumable sets to commercial customers, as well as for research customers developing new therapeutic applications for Cytori Cell Therapy in Europe, Japan, and other regions. In addition, the company provides StemSource devices, including a cryogenic freezer, measuring and monitoring equipment, and a database patient tracking system, as well as offers consulting, installation, and training services. Cytori Therapeutics, Inc. markets its products to hospitals, clinics, tissue banks, and stem cell banking companies through direct sales reps, distributors, and partners worldwide. The company was founded in 1996 and is headquartered in San Diego, California.

 

Traders Recap: Vishay Intertechnology, Inc. (VSH), Old Republic International Corporation (ORI), TTM Technologies, Inc. (TTMI)

Vishay Intertechnology, Inc. (VSH) failed to extend gains with the stock declining -1.28% or $-0.21 to close the day at $16.19 on higher than average trading volume of 1.38M shares, compared to its three month average trading volume of 1.02M. The Malvern Pennsylvania 19355 based company has been outperforming the semiconductor – broad line companies by 6.8253% for last three months and its recent gains have offset losses to -0.06% YTD, versus the semiconductor – broad line industry which is up 6.75% for the same period. The RSI of 48.07 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the Americas, Europe, and Asia. The company operates in five segments: MOSFETs, Diodes, Optoelectronic Components, Resistors & Inductors, and Capacitors. The MOSFETs segment offers low- and medium-voltage TrenchFET MOSFETs, high-voltage planar MOSFETs, high voltage super junction MOSFETs, power integrated circuits, and integrated function power devices. The Diodes segment provides rectifiers, small signal diodes, protection diodes, thyristors or silicon-controlled rectifiers, power modules, and IGBTs. The Optoelectronic segment provides standard and customer specific optoelectronic components, such as infrared (IR) emitters and detectors, IR remote control receivers, optocouplers, solid-state relays, optical sensors, light-emitting diodes, 7-segment displays, and IR data transceiver modules. The Resistors & Inductors segment provides film, wirewound, power metal strip, crowbar and steel blade, variable, and non-linear resistors, as well as battery management shunts, thermo fuses, chip fuses, pryotechnic initiators/ignitors, networks/arrays, magnetics, and connectors. The Capacitors segment offers tantalum, ceramic, film, power, heavy-current, and aluminum electrolytic capacitors. The company’s semiconductor components are used for power control, power conversion, power management, signal switching, signal routing, signal blocking, signal amplification, two-way data transfer, one-way remote control, and circuit isolation functions; and passive components are used to restrict current flow, suppress voltage increases, store and discharge energy, control alternating current and voltage, filter out unwanted electrical signals, and perform other functions. It serves industrial, computing, automotive, consumer, telecommunications, military, power supplies, aerospace, and medical markets. The company was founded in 1962 and is headquartered in Malvern, Pennsylvania.

Old Republic International Corporation (ORI) had a light trading with around 1.37M shares changing hands compared to its three month average trading volume of 1.86M. The stock traded between $20.63 and $20.8 before closing at the price of $20.73 with -0.24% change on the day. The Chicago Illinois 60601 based company is currently trading 26.9% above its 52 week low of $16.51 and -2.17% below its 52 week high of $21.19. Both the RSI indicator and target price of 70.35 and $23 respectively, lead us to believe that it could drop over the coming weeks.

Old Republic International Corporation, through its subsidiaries, engages in the insurance underwriting and related services business primarily in the United States and Canada. The company operates through three segments: General Insurance Group, Title Insurance Group, and the Republic Financial Indemnity Group Run-off Business. The General Insurance Group segment offers automobile extended warranty, aviation, commercial automobile, commercial multi-peril, general liability, home warranty, inland marine, travel accident, and workers’ compensation insurance products; and financial indemnity products for specialty coverages, including errors and omissions, directors and officers, fidelity, guaranteed asset protection, and surety. This segment offers its insurance products for businesses, government, and other institutions in transportation, commercial construction, healthcare, education, retail and wholesale, forest products, energy, general manufacturing, and financial services industries. The Title Insurance Group segment provides lenders’ and owners’ title insurance policies to real estate purchasers and investors based upon searches of the public records. This segment also offers escrow closing and construction disbursement services; and real estate information products, national default management services, and other services pertaining to real estate transfers and loan transactions. The Republic Financial Indemnity Group Run-off Business segment provides private mortgage insurance coverage that protects mortgage lenders and investors from default related losses on residential mortgage loans made primarily to homebuyers. This segment is also involved in the consumer credit indemnity run-off business. Old Republic International Corporation was founded in 1887 and is based in Chicago, Illinois.

TTM Technologies, Inc. (TTMI) traded within a range of $17.28 to $17.54 after opening the day at $17.44. The company has seen its stock increase in value by 28.25% so far this year. The stock was down close to -0.85% on light volume in last trading session and closed at $17.48 per share. After the recent fall, the stock is currently holding -2.13% below its 52 week high of $17.86 and 188.93% above its 12-month low of $6.05. The shares are up by over 17.16% in the last three months, and the RSI indicator value of 76.15 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

TTM Technologies, Inc., together with its subsidiaries, manufactures printed circuit boards (PCBs) worldwide. It provides a range of PCBs and electro-mechanical solutions, including high density interconnect PCBs, conventional PCBs, flexible PCBs, rigid-flex PCBs, custom assemblies and system integration, and IC substrates. It also produces test specialized circuits used in radio-frequency or microwave emission and collection applications; printed circuits with heavy copper cores, and embedded and press-fit coins; PCBs with electrically passive heat sinks; and PCBs with electrically active thermal cores. In addition, the company offers various services, including manufacturability, PCB layout design, simulation and testing, and quick turnaround services. The company’s customers include original equipment manufacturers and electronic manufacturing services companies that primarily serve the networking/communications, cellular phone, computing, aerospace and defense, and medical/industrial/instrumentation end markets of the electronics industry. TTM Technologies, Inc. was founded in 1978 and is headquartered in Costa Mesa, California.